Ephemeral seeds: Microembolization of tumor cells during surgery

Annals of Surgical Oncology

Volumn 6, Issue 7, 1999, Pages 631-632

  Tanabe, K K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RECURRENCE; EDITORIAL; HYPERTHERMIC THERAPY; MELANOMA; METASTASIS; ORGAN PERFUSION; POLYMERASE CHAIN REACTION; TUMOR CELL;

EID: 0032743406     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-999-0631-1     Document Type: Editorial

References (4)

1. 1. ET Krementz RF Ryan JH Muchmore RD Carter CM Sutherland RJ Reed 1992 Hyperthermic Region Perfusion for Melanoma of the Limbs CM Balch AN Houghton GW Milton AJ Sober S-J Soong Cutaneous Melanoma 2 J. B. Lippincott Company Philadelphia 403 426 Krementz ET, Ryan RF, Muchmore JH, Carter RD, Sutherland CM, Reed RJ. (1992) Hyperthermic Region Perfusion for Melanoma of the Limbs. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong S-J Cutaneous Melanoma. 2 J. B. Lippincott Company Philadelphia403–26.
2. 2. JF Thompson DT Lai C Ingvar PC Kam 1994 Maximizing efficacy and minimizing toxicity in isolated limb perfusion for melanoma Melanoma Res 4 1 45 50 Thompson JF, Lai DT, Ingvar C, Kam PC. (1994) Maximizing efficacy and minimizing toxicity in isolated limb perfusion for melanoma. Melanoma Res 4(1)45–50.
3. 3. PC Wu A McCarty SM Hewitt E Turner SK Libutti DL Bartlett HR Alexander 1999 Isolated organ perfusion does not result in systemic microembolization of tumor cells Ann Surg Oncol 6 658 663 Wu PC, McCarty A, Hewitt SM, Turner E, Libutti SK, Bartlett DL, Alexander HR. (1999) Isolated organ perfusion does not result in systemic microembolization of tumor cells. Ann Surg Oncol 6:658–63.
4. 4. IJ Fidler 1970 Metastasis: Quantitative analysis of distribution and fate of tumor embolilabeled with 125I-5-iodo-29-deoxyuridine J Natl Cancer Inst 45 773 782 Fidler IJ. (1970) Metastasis: Quantitative analysis of distribution and fate of tumor embolilabeled with 125I-5-iodo-29-deoxyuridine. J Natl Cancer Inst 45:773–82.